Secondary causes of hyperlipidemia
Tài liệu tham khảo
Agorastos, 1976, Plasma lipoproteins in liver disease, Biochem Soc Trans, 4, 593, 10.1042/bst0040593
Anderson, 1988, Body fat distribution, plasma lipids, and lipoproteins, Arteriosclerosis, 8, 88, 10.1161/01.ATV.8.1.88
Anderson, 1993, Hyperlipoproteinemia in adults with renal disease. Mayo Clin, Proc, 68, 358
Appel, 1985, The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure and Viscosity, N Engl J Med, 312, 1544, 10.1056/NEJM198506133122404
Applebaum-Bowden, 1987, The dyslipoproteinemia of anabolic steroid therapy: Increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein cholesterol, Metabolism, 36, 949, 10.1016/0026-0495(87)90130-2
Arden, 1990, Effect of weight restoration on the dyslipoproteinemia of anorexia nervosa, J Adolesc Health Care, 11, 199, 10.1016/0197-0070(90)90348-6
Arem, 1990, Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy, Arch Intern Med, 150, 2097, 10.1001/archinte.1990.00390210077017
Bagdade, 1976, Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man, J Lab Clin Med, 87, 37
Bagdade, 1967, Diabetic lipemia: Form of acquired fat-induced lipemia, N Engl J Med, 276, 427, 10.1056/NEJM196702232760802
Bagdade, 1970, Steroid-induced lipemia. A complication of high dosage corticosteroid therapy, Arch Intern Med, 125, 129, 10.1001/archinte.1970.00310010131015
Bagdade, 1970, Steroid induced lipemia Arch Intern Med, 125, 129
Baldo-Enzi, 1990, Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids, Metabolism, 39, 203, 10.1016/0026-0495(90)90076-O
Ball, 1991, Asymptomatic hypothyroidism and hypercholes-terolaemia, J R Soc Med, 84, 527, 10.1177/014107689108400908
Ballantyne, 1989, Effects of cyclosporine therapy on plasma lipoprotein levels, JAMA, 262, 53, 10.1001/jama.1989.03430010065032
Becker, 1988, Relationship between corticoid exposure and plasma lipid levels in heart transplant recipients, Am J Med, 85, 632, 10.1016/S0002-9343(88)80234-1
Bershad, 1985, Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne, N Engl J Med, 313, 981, 10.1056/NEJM198510173131604
Brüning, 1988, Tamoxifen, serum lipoproteins and cardiovascular risk, Br J Cancer, 58, 497, 10.1038/bjc.1988.248
Brunzell, 1973, Evidence for a common saturable triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man, J Clin Invest, 15, 78
Busnach, 1991, Impaired efficacy of selective LDL-apher-esis in primary biliary cirrhosis, Int J Artif Organs, 14, 246, 10.1177/039139889101400409
Byington, 1990, Propranolol-induced lipid changes and their prognostic significance after an MI: the Beta Blocker Heart Attack Trial experience, Am J Cardiol, 65, 1287, 10.1016/0002-9149(90)91314-V
Calandre, 1992, The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients, Epilepsia, 33, 154, 10.1111/j.1528-1157.1992.tb02299.x
Cattran, 1976, Defective triglyceride removal in lipemia associated with peritoneal dialysis and hemodialysis, Ann Intern Med, 85, 29, 10.7326/0003-4819-85-1-29
Cattran, 1979, Hyperlipidemia after renal transplantation: Natural history and pathophysiology, Ann Intern Med, 91, 554, 10.7326/0003-4819-91-4-554
Chait, 1990, Acquired hyperlipidemia (secondary dyslipoproteinemias), Endocrinol Meta Clin North Am, 19, 259, 10.1016/S0889-8529(18)30324-4
Chait, 1972, Clinical and metabolic study of alcoholic hyperlipidaemia, Lancet, 2, 62, 10.1016/S0140-6736(72)91552-8
Chait, 1981, Chylomicronemia syndrome in diabetes mellitus, Diabetes Care, 4, 343, 10.2337/diacare.4.3.343
Chan, 1989, Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: The role of postheparin lipases in the metabolism of high-density lipoprotein subfractions, Metabolism, 38, 939, 10.1016/0026-0495(89)90003-6
Chetkowski, 1986, Biologic effects of transdermal estradiol, N Engl J Med, 314, 1615, 10.1056/NEJM198606193142505
Clarkson, 1989, From menarche to menopause: Coronary artery atherosclerosis and protection in cynomolgus monkeys, Am J Obstet Gynecol, 160, 1280, 10.1016/S0002-9378(89)80013-4
Coleman, 1990, Topical timolol decreases plasma high-density lipoprotein cholesterol level, Arch Ophthalmol, 108, 1260, 10.1001/archopht.1990.01070110076028
Curry, 1977, Status of the coronary arteries in the nephrotic syndrome, Am J Med, 63, 183, 10.1016/0002-9343(77)90231-5
Cust, 1992, Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins, Am J Obstet Gynecol, 166, 950, 10.1016/0002-9378(92)91370-P
D'Amico, 1989, Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients, Kidney Int, 36, 266
Davidoff, 1973, Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy, N Engl J Med, 289, 552, 10.1056/NEJM197309132891103
Day, 1982, Adrenergic mechanisms in control of plasma lipid concentrations, BMJ, 284, 1145, 10.1136/bmj.284.6323.1145
Day, 1979, Metabolic consequences of atenolol and propranolol in treatment of essential hypertension, BMJ, 1, 77, 10.1136/bmj.1.6156.77
Day, 1979, Lecithin cholesterol acyltransferase and the lipoprotein abnormalities of parenchymal liver disease, Clin Sei, 56, 575, 10.1042/cs0560575
de Bruin, 1993, Lipoprotein(a) and apoli-poprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects, J Clin Endocrinol Metab, 76, 121
Diamond, 1989, Hyperlipidemia of nephrosis: Pathophysiologic role in progressive glomerular disease, Am J Med, 87, 25
Drukker, 1986, Hyperlipidemia after renal transplantation in children on alternate day corticosteroid therapy, Clin Nephrol, 26, 140
Dunn, 1981, Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus, Ann Intern Med, 95, 426, 10.7326/0003-4819-95-4-426
Ende, 1960, Serum cholesterol in acute starvation: A report of 20 cases, J Nutr, 71, 85, 10.1093/jn/71.1.85
Ettinger, 1987, Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids, Am J Med, 83, 503, 10.1016/0002-9343(87)90762-5
Ettinger, 1988, Prednisone increases VLDL and HDL in healthy men, Metabolism, 37, 1055, 10.1016/0026-0495(88)90067-4
Ettinger, 1988, Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus, J Clin Endocrinol Metab, 67, 425, 10.1210/jcem-67-3-425
Ettinger, 1987, Effect of low dose, short-term prednisone on plasma lipids, Atherosclerosis, 63, 167, 10.1016/0021-9150(87)90117-1
Farmer, 1991, Lipoprotein(a) and apolipoprotein changes after cardiac transplantation, J Am Coll Cardiol, 18, 926, 10.1016/0735-1097(91)90748-X
Franzoni, 1992, Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs, Epilepsia, 33, 932, 10.1111/j.1528-1157.1992.tb02203.x
Fröhlich, 1989, Lipid profile of body builders with and without self-administration of anabolic steroids, Eur J Appl Physiol, 59, 98, 10.1007/BF02396586
Gao, 1987, Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient, Circulation, 76, V56
Gardner, 1928, The relationship of serum cholesterol and basal metabolism, BMJ, 2, 935, 10.1136/bmj.2.3542.935
Garg, 1990, Management of dyslipidemia in NIDDM, Diab Care, 13, 153, 10.2337/diacare.13.2.153
Ginsberg, 1991, Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons, Ann Intern Med, 151, 1925
Glazer, 1991, Atherogenic effects of anabolic steroids on serum lipids levels, Arch Intern Med, 151, 1925, 10.1001/archinte.1991.00400100013003
Glueck, 1969, A new mechanism of exogenous hyperglyceri-demia, Ann Intern Med, 71, 1051, 10.7326/0003-4819-71-6-1051
Glueck, 1991, The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia, Clin Chim Acta, 201, 113, 10.1016/0009-8981(91)90032-8
Glueck, 1969, Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance, Am J Med, 47, 318, 10.1016/0002-9343(69)90158-2
Glueck, 1972, Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia, Metabolism, 21, 657, 10.1016/0026-0495(72)90089-3
Gonyea, 1992, Weight change and serum lipoproteins in recipients of renal allografts. Mayo Clin, Proc, 67, 653
Grainger, 1988, Effects of Cimetidine and ranitidine on plasma high-density lipoprotein subclasses in humans, Pharmacology, 36, 420, 10.1159/000138331
Grimm, 1986, Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension, Am J Med, 88, 56, 10.1016/0002-9343(86)90161-0
Grundy, 1990, Management of hyperlipidemia of kidney disease, Kidney Int, 37, 847, 10.1038/ki.1990.57
Grundy, 1989, Rationale and management of hyperlipidemia of the nephrotic syndrome, Am J Med, 87, 3
Grundy, 1988, Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism, Kidney Int, 33, 1160, 10.1038/ki.1988.125
Harris, 1989, Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review, J Lipid Res, 30, 785, 10.1016/S0022-2275(20)38310-3
Hazzard, 1969, Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives, N Engl J Med, 280, 471, 10.1056/NEJM196902272800904
Hazzard, 1989, Applebaum-Bowden D: Why women live longer than men: The biologic mechanism of the sex differential in longevity, Trans Am Clin Climatol Assoc, 101, 168
Hazzard, 1972, Aggravation of broad-ß disease (type 3 hyperlipoproteinemia) by hypothyroidism, Arch Intern Med, 130, 822, 10.1001/archinte.1972.03650060018004
Henkin, 1992, Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice, JAMA, 267, 961, 10.1001/jama.1992.03480070077035
Hoggwerf, 1984, Effect of Cimetidine on serum lipids and lipoproteins, Clin Pharmacol Ther, 36, 217, 10.1038/clpt.1984.165
Hulley, 1985, Systolic hypertension in the elderly program (SHEP): Antihypertensive efficacy of chlorthalidone, Am J Cardiol, 56, 913, 10.1016/0002-9149(85)90404-7
Humphrey, 1980, Lipid metabolism in pregnancy. VII. Kinetics of chylomicron triglyceride removal in fed pregnant rat, Am J Physiol, 239, E81
Series, 1988, Thyroid dysfunction and hypercholesterolae-mia in the general population of Glasgow, Scotland, Clin Chim Acta, 172, 217, 10.1016/0009-8981(88)90326-9
Jacoby, 1992, Acute myocardial infarction in the diabetic patient: Pathophysiology, clinical course, and prognosis, J Am Coll Cardiol, 20, 736, 10.1016/0735-1097(92)90033-J
Joven, 1990, Abnormalities in lipoprotein metabolism in patients with nephrotic syndrome, N Engl J Med, 323, 579, 10.1056/NEJM199008303230905
Jungst, 1987, Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome, Clin Chim Acta, 168, 159, 10.1016/0009-8981(87)90285-3
Kannel, 1990, Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience, Am Heart J, 120, 672, 10.1016/0002-8703(90)90026-T
Kaplan, 1989, The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension, Arch Intern Med, 149, 1514, 10.1001/archinte.1989.00390070054005
Karadi, 1989, Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin, Clin Chem, 35, 2121, 10.1093/clinchem/35.10.2121
Kasiske, 1987, Persistent hyperlipidemia in renal transplant patients, Medicine (Bait), 66, 309, 10.1097/00005792-198707000-00003
Katz, 1980, Elevation of serum triglyceride levels from oral isotretinoin in disorders of keratinization, Arch Dermatol, 116, 1369, 10.1001/archderm.1980.01640360043015
Keilani, 1993, Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor, Ann Intern Med, 118, 246, 10.7326/0003-4819-118-4-199302150-00002
Kesaniemi, 1983, Increased low density lipoprotein production associated with obesity, Arteriosclerosis, 3, 170, 10.1161/01.ATV.3.2.170
Klinefelter, 1965, Hypercholesterolemia in anorexia nervosa, J Clin Endocrinol, 25, 1520, 10.1210/jcem-25-11-1520
Knopp, 1981, Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: Relationships to estrogen and progestin potency, J Clin Endocrinol Metab, 53, 1123, 10.1210/jcem-53-6-1123
Kobashigawa, 1990, Low-dose lovastatin safely lowers cholesterol after cardiac transplantation, Circulation, 82, IV-281
Lees, 1970, Hyperbeta-lipoproteinemia in acute intermittent porphyria, N Engl J Med, 282, 432, 10.1056/NEJM197002192820807
Lewis, 1975, Autoimmune hyperlipidemia in a patient. Atherosclerotic course and changing immunoglobulin pattern during 21 years of study, Am J Med, 59, 208, 10.1016/0002-9343(75)90355-1
Lindner, 1988, Expression of type III hyperlipoproteinemia in an adolescent patient with hypothyroidism, J Pediatr, 90, 86, 10.1016/S0022-3476(88)80536-5
McGonigle, 1981, Labetalol and lipids, Lancet, 2, 163, 10.1016/S0140-6736(81)90759-5
McMurray, 1991, Changes in lipid and lipoprotein levels and body weight in Tarahumara Indians after consumption of an affluent diet, N Engl J Med, 325, 1704, 10.1056/NEJM199112123252405
Melnik, 1987, Characterization of apoprotein metabolism and thero-genic lipoproteins during oral isotretinoin treatment, Dermatologia, 175, 158, 10.1159/000248880
Menon, 1991, Cyclosporin A blood levels are not influenced by dietary alterations in lipids, Res Commun Chem Pathol Pharmacol, 72, 203
Mensink, 1989, Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy men and women, N Engl J Med, 321, 436, 10.1056/NEJM198908173210705
Merians, 1985, Relationship of exercise, oral contraceptive use and body fat to concentrations of plasma lipids and lipoprotein cholesterol in young women, Am J Med, 78, 913, 10.1016/0002-9343(85)90212-8
Miller, 1992, Effects of adrenoreceptor-blocking drugs on plasma lipoprotein concentrations, Am J Cardiol, 60, 17, 10.1016/0002-9149(87)90537-6
Miller, 1983, Cimetidine and high density lipoprotein cholesterol, Lancet, 1, 529, 10.1016/S0140-6736(83)92217-1
Montes, 1984, Physiologie and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum, Possible markers for the diagnosis of "prelipemia." Arteriosclerosis, 4, 40
Mordasini, 1977, Selective deficiency of hepatic triglyceride lipase in uremic patients, N Engl J Med, 297, 1362, 10.1056/NEJM197712222972502
Moser, 1989, Lipid abnormalities and diuretics, Am Fam Physician, 40, 213
Nestel, 1974, Cholesterol metabolism in anorexia nervosa and hypercholesterolemia, J Clin Endocrinol Metab, 38, 325, 10.1210/jcem-38-2-325
Nikkila, 1978, Increase of serum high-density lipoprotein in phenytoin users, BMJ, 2, 99, 10.1136/bmj.2.6130.99
Notelovitz, 1989, Lipid and lipoprotein changes in women taking low-dose triphasic oral contraceptives: A controlled, comparative, 12 month clinical trial, Am J Obstet Gynecol, 160, 1269, 10.1016/S0002-9378(89)80012-2
O'Leary, 1987, Changes in serum lipoproteins and high-density lipoprotein composition during isotretinoin therapy, Clin Invest Med, 10, 355
Phinney, 1991, The transient hypercholesterolemia of major weight loss, Am J Clin Nutr, 53, 1404, 10.1093/ajcn/53.6.1404
Porte, 1966, Relation between postheparin lipolytic activity and plasma triglyceride in myxedema, Metabolism, 15, 107, 10.1016/0026-0495(66)90031-X
Potter, 1979, The hyperlipidemia of pregnancy in normal and complicated pregnancies, Am J Obstet Gynecol, 133, 165, 10.1016/0002-9378(79)90469-1
Rapoport, 1978, Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis, N Engl J Med, 299, 1326, 10.1056/NEJM197812142992402
Ratkovec, 1990, Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation, J Thorac Cardiovascular Surg, 100, 6, 10.1016/S0022-5223(19)35592-8
Reddy, 1985, Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol and apolipoproteins A and B in children with epilepsy, Proc Soc Exp Biol Med, 180, 359, 10.3181/00379727-180-42189
Reeves, 1976, Hyperlipidemia due to oxymetholone therapy. Occurrence in a long-term hemodialysis patient, JAMA, 236, 469, 10.1001/jama.1976.03270050025023
Rudas, 1990, Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantation, Am J Cardiol, 66, 1135, 10.1016/0002-9149(90)90518-6
Sanderson, 1991, Successful hyperlipemic pregnancy, JAMA, 265, 1858, 10.1001/jama.1991.03460140086032
Saudek, 1977, The effect of hepatitis B on plasma cholesterol and sterol balance, Am J Med, 63, 453, 10.1016/0002-9343(77)90285-6
Schneider, 1987, Failure to reduce cholesterol as explanation for the limited efficacy of antihypertensive treatment in the reduction of coronary heart disease. Evidence from the Hypertension Detection and Follow-up program (1973-1979), Nephron, 47, 104, 10.1159/000184564
Seidel, 1987, Lipoproteins in liver disease, J Clin Chem Clin Biochem, 25, 541
Seidel, 1970, A lipoprotein characterizing obstructive jaundice, J Clin Invest, 49, 2396, 10.1172/JCI106459
Sheu, 1990, Effect of prazosin treatment on HDL kinetics in patients with hypertension, Am J Hypertens, 3, 761, 10.1093/ajh/3.10.761
Simon, 1970, Serum cholesterol esterification in liver disease, N Engl J Med, 283, 841, 10.1056/NEJM197010152831604
Smith, 1991, HMG-CoA reductase inhibitor-induced myopathy in the rat: Cyclosporine A interaction and mechanism studies, J Pharmacol Exp Ther 1, 257, 1225
Stamler, 1988, Frequency of hypercholesterolemia after cardiac transplantation, Am J Cardiol, 62, 1268, 10.1016/0002-9149(88)90272-X
Stanczyk, 1988, A randomized comparison of nonoral estradiol delivery in postmenopausal women, Am J Obstet Gynecol, 159, 1540, 10.1016/0002-9378(88)90591-1
Superko, 1990, Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation, Am J Cardiol, 66, 1131, 10.1016/0002-9149(90)90517-5
Superko, 1989, Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia, Am J Med, 86, 26, 10.1016/0002-9343(89)90125-3
Taylor, 1989, Hyperlipidemia after clinical heart transplantation, J Heart Transplant, 8, 209
Thompson, 1981, Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo, Proc Natl Acad Sei USA, 78, 2592, 10.1073/pnas.78.4.2591
Thompson, 1989, Contrasting effects of testosterone and stanozolol on serum lipoprotein levels, JAMA, 261, 1165, 10.1001/jama.1989.03420080085036
Thompson, 1979, Unexpected decrease in plasma high density lipoprotein cholesterol with weight loss, Am J Clin Nutr, 32, 2016, 10.1093/ajcn/32.10.2016
Uretsky, 1987, Development of coronary artery disease in cardiac transplant patients treated with cyclosporine and prednisone, Circulation, 76, 827, 10.1161/01.CIR.76.4.827
Valbonesi, 1988, Plasma exchange for the management of cyclosporin A-induced hypereniglyceridemia, Int J Artif Organs, 11, 209, 10.1177/039139888801100315
Vega, 1988, Levels of cofactors for lipoprotein lipase and lecithin-cholesterol acyltransferase in plasma patients with severe thermal injury, J Burn Care Rehabil, 9, 18, 10.1097/00004630-198801000-00006
Vega, 1988, Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism, Kidney Int, 33, 1160, 10.1038/ki.1988.125
Wahl, 1983, Effect of estrogen progestin potency on lipid/ lipoprotein cholesterol, N Engl J Med, 308, 862, 10.1056/NEJM198304143081502
Wass, 1979, Does the nephrotic syndrome increase the risk of cardiovascular disease?, Lancet, 2, 664, 10.1016/S0140-6736(79)92067-1
Webb, 1993, Does cyclosporin increase lipoprotein (a) concentrations in renal transplant recipients, Lancet, 1, 268, 10.1016/0140-6736(93)92616-2
Weinberger, 1992, Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk, Am J Med, 80, 64
Wiersinga, 1991, An increase in plasma cholesterol independent of thyroid function during long term amiodarone therapy: A dose-dependent relationship, Ann Intern Med, 114, 128, 10.7326/0003-4819-114-2-128
Wolf, 1983, Influence of weight reduction on plasma lipoproteins in obese patients, Arteriosclerosis, 3, 160, 10.1161/01.ATV.3.2.160
Young, 1953, Reducing and post reducing maintenance on the moderate fat diet, Journal of the American Dietetic Association, 29, 890, 10.1016/S0002-8223(21)31956-3
Zimmerman, 1984, The effects of prednisone therapy on plasma lipoproteins and apoproteins: A prospective study, Metabolism, 33, 521, 10.1016/0026-0495(84)90006-4
Zimmerman, 1984, Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition, Arteriosclerosis, 4, 115, 10.1161/01.ATV.4.2.115
